Fludrocortisone 0.1 Milligrams (mg)
Phase 3Small molecule
Fludrocortisone 0.1 Milligrams (mg) is one of 5 small molecule programs targeting Adrenal insufficiency. It is currently in Phase 3.
1
Indications
2
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Adrenal Insufficiency
#DrugCompanyPhaseTrials
1Cortef
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Rayos
RRoxane Laboratories
Approved
Fludrocortisone 0.1 Milligrams (mg)
GGanin Fertility Center
Phase 3
Megace
Bristol-Myers SquibbPreclinical
Glucocorticoids
NovartisPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- GGanin Fertility Center